Analysts' Weekly Ratings Changes for Regeneron Pharmaceuticals
They now have a "hold" rating on the stock. 5/15/2017 - Regeneron Pharmaceuticals had its "hold" rating reaffirmed by analysts at Cowen and Company.
from Biotech News
They now have a "hold" rating on the stock. 5/15/2017 - Regeneron Pharmaceuticals had its "hold" rating reaffirmed by analysts at Cowen and Company.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments